Liquid Biopsy Market

Liquid Biopsy Market, By Biomarker Type (CTC (Circulating Tumor Cells), ctNA (Circulating Tumor Nucliec Acids), Exosomes), By Sample Type (Blood, Urine, Others), By Disease Indication (Lung Cancer, Gastrointestinal Cancer, Prostate Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Others, etc.), By End User (Hospitals, Cancer Institutes, Academic Institutes, Diagnostic Centers), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

Table of Contents 1. Research Objective and Assumption o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snippet, By Biomarker Type  Market Snippet, By Sample Type  Market Snippet, By Disease Indication  Market Snippet, By End User o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Drivers o Restraints o Market Opportunities o Impact Analysis o Key Developments o Technological Advancement o Regulatory Scenario 4. Global Liquid Biopsy Market, By Biomarker Type, 2021– 2033, (US$ Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022–2033  Segment Trends o CTC (Circulating Tumor Cells)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn) o ctNA (Circulating Tumor Nucliec Acids)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn) o Exosomes  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn) 5. Global Liquid Biopsy Market, By Sample Type, 2021 – 2033 (US$ Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022–2033  Segment Trends o Blood  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn) o Urine  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn) 6. Global Liquid Biopsy Market, By Disease Indication 2021– 2033, (US$ Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 – 2033  Segment Trends o Lung Cancer  Introduction  Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million) o Gastrointestinal Cancer  Introduction  Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million) o Prostate Cancer  Introduction  Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million) o Breast Cancer  Introduction  Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million) o Colorectal Cancer  Introduction  Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million) o Leukemia  Introduction  Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million) o Others  Introduction  Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million) 7. Global Liquid Biopsy Market, By End User 2021– 2033, (US$ Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 – 2033  Segment Trends o Hospitals  Introduction  Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million) o Cancer Institutes  Introduction  Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million) o Academic Institutes  Introduction  Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million) o Diagnostic Centers  Introduction  Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Million) 8. Global Liquid Biopsy Market, By Region, 2021– 2033, (US$ Mn) o Introduction  Market Share Analysis, By Region, 2026 and 2033 (%)  Y-o-Y Growth Analysis, For Regions, 2022–2033 o North America  Market Size and Forecast, By Biomarker Type, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Sample Type, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Disease Indication, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By End User, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Country, 2021 – 2033, (US$ Mn) o U.S. o Canada o Latin America  Market Size and Forecast, By Biomarker Type, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Sample Type, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Disease Indication, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By End User, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Country, 2021 – 2033, (US$ Mn) o Brazil o Mexico o Argentina o Rest of Latin America o Europe  Market Size and Forecast, By Biomarker Type, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Sample Type, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Disease Indication, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By End User, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Country, 2021 – 2033, (US$ Mn) o Germany o U.K. o France o Italy o Spain o Russia o Rest of Europe o Asia Pacific  Market Size and Forecast, By Biomarker Type, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Sample Type, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Disease Indication, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By End User, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Country, 2021 – 2033, (US$ Mn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of APAC o Middle East  Market Size and Forecast, By Biomarker Type, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Sample Type, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Disease Indication, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By End User, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Country, 2021 – 2033, (US$ Mn) o GCC o Israel o Rest of Middle East o Africa  Market Size and Forecast, By Biomarker Type, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Sample Type, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Disease Indication, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By End User, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Country, 2021 – 2033, (US$ Mn) o South Africa o Central Africa o North Africa 9. Competitive Landscape o Company Profiles  Biocept, Inc. o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Qiagen N.V o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Trovagene, Inc. o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Janssen Global Services, LLC o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  MDxHealth SA o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Natera, Inc. o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  F. Hoffmann-La Roche Ltd o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Silicon Biosystems o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Pathway Genomics Corporation o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Sysmex Corporation o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies 10. Section o References o Research Methodology o About us and Sales Contact *Browse 24 market data tables and 20 figures on “Liquid Biopsy – Global forecast to 2033.